About: ImageneBio, Inc., a clinical-stage biopharmaceutical company, develops therapeutics for patients with immunological, autoimmune and inflammatory diseases. Its lead product candidate includes IMG-007, a non-depleting anti-OX40 monoclonal antibody that binds to OX40 receptor on activated T cells to block receptor binding to OX40 ligand which is in Phase 1b/2a clinical trial. The company was formerly known as Ikena Oncology, Inc. and changed its name to ImageneBio, Inc. in July 2025. ImageneBio, Inc. is headquartered in San Diego, California.
Sector: Healthcare
Industry: Biotechnology
Latest price: $4.89 (-2.59%)
IMA NASDAQ ImageneBio, Inc.
ImageneBio, Inc. share price
IMA price activity
Last Price
$4.890
Change (24hr)
-0.13 USD (-2.59%)
Volume
73.15K
Volume (4w avg)
-
Open
$5.18
Day Range
$4.64 - $5.24
Previous Close
$5.02
Last Trade
18 Sep, 8:00 pm GMT+0
Delayed
18 Sep, 8:00 pm GMT+0
IMA price performance
Delayed
18 Sep, 8:00 pm GMT+0
IMA Market Signals